Sort   by:  
 Page size 
UnknownExpanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events.
Not available
S-EPMC10474064 | biostudies-literature
UnknownEpidemiological trends of HIV/HCV coinfection in Spain, 2015-2019.
Not available
S-EPMC9543728 | biostudies-literature
UnknownRepurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
Not available
S-EPMC7727327 | biostudies-literature
UnknownHCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients.
Not available
S-EPMC8010945 | biostudies-literature
UnknownRapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR.
Not available
S-EPMC6704069 | biostudies-literature
UnknownSpatiotemporal Characteristics of the Largest HIV-1 CRF02_AG Outbreak in Spain: Evidence for Onward Transmissions.
Not available
S-EPMC6421502 | biostudies-literature
UnknownDiscovering HIV related information by means of association rules and machine learning.
Not available
S-EPMC9616424 | biostudies-literature
UnknownLong-term effectiveness and tolerability of dolutegravir/lamivudine in treatment-naive people with HIV: an analysis of a multicentre cohort at 96 weeks.
Not available
S-EPMC11879157 | biostudies-literature
UnknownChanges in Body Mass Index in Children and Adolescents Living With Human Immunodeficiency Virus in Europe and Thailand Starting Dolutegravir.
Not available
S-EPMC12712701 | biostudies-literature
UnknownEffectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice.
Not available
S-EPMC10232237 | biostudies-literature
Sort   by:  
 Page size